Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01349998Phase 3Completed
A Phase 3 trial of luliconazole in tinea pedis, Tinea cruris (TC), tinea corporis, sponsored by Tinea Pharmaceuticals, Inc.. Started May 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01349998.